Re: The Price War....?
If you look at the OWs contact, NOvavax gets about $1B for the trials, administrative costs, etc. The line item for 100M doses was a little over $400M. I think Fuji is being paid separately by OWS for manufacturing of the antigen. Novavax is buying the Matrix-M under OWS also. So the $4 a dose must cover the fill/finish, packaging and shipping costs plus a small profit. The DOD contract was $60M for 10M doses, but not sure what was included in that contract.